News | Peripheral Artery Disease (PAD) | January 13, 2025

Study: Disparities in Peripheral Artery Disease Treatment Lead to Amputation

A recently released study reports persistent disparities in outcomes for people with peripheral artery disease.


A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more severe form, chronic limb-threatening ischemia (CLTI) in the United States.

The study, “Racial, Socioeconomic, and Geographic Disparities in Preamputation Vascular Care for Patients With Chronic Limb-Threatening Ischemia," followed patients in the year leading up to their amputation.

Researchers evaluated the association between race, rurality, socioeconomic status (SES), and preamputation vascular care. According to the study, Black patients, those with low SES, and those living in rural areas have elevated rates of major lower extremity amputation, which may be related to a lack of subspecialty chronic limb-threatening ischemia care.

Among 73,237 patients who underwent major lower extremity amputation, 55.1% had an outpatient vascular subspecialist visit, 82.1% had lower extremity arterial testing, and 38.7% underwent lower extremity revascularization in the year before amputation. Black patients were less likely to have an outpatient vascular specialist visit or revascularization than White patients.

Compared with patients without low SES or residing in urban areas, patients with low SES or residing in rural areas were less likely to have an outpatient vascular specialist visit. 

Researcherchers concluded tbqt Black race, rural residence, and low SES are associated with failure to receive subspecialty chronic limb-threatening ischemia care before amputation. To reduce disparities in amputation, multilevel interventions to facilitate equitable chronic limb-threatening ischemia care are needed.

Study coauthor Alexander Fanaroff, MD, MHS, said, “Every patient that has an amputation for chronic limb-threatening ischemia represents a failure to deliver quality care aimed at amputation prevention. This includes revascularization, which has a clear benefit in preventing major lower extremity amputation. It’s easy to find and point out procedures that shouldn’t have been done, but it’s harder to find and point out procedures that should have been done but weren’t. This research is a start in that direction. This research should be a call to health systems, policymakers, and other stakeholders to make it easier for patients—especially the most vulnerable patients—to access PAD-specific care.” Fanaroff is  an interventional cardiologist and assistant professor of medicine at the University of Pennsylvania.

The study was supported by a SCAI Early Career Research Grant.


Related Content

News | Peripheral Artery Disease (PAD)

Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...

Home January 13, 2025
Home
News | Peripheral Artery Disease (PAD)

Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...

Home December 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...

Home December 03, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
News | Peripheral Artery Disease (PAD)

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

Home May 16, 2024
Home
News | Peripheral Artery Disease (PAD)

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
Subscribe Now